Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Pharma Stock Roundup: Novo Nordisk's New Obesity Pill Data, Roche, AstraZeneca's Pipeline Updates
Article By:
Zacks Investment Research
Saturday, March 9, 2024 1:40 PM EDT
This week, data from Novo Nordisk’s early-stage study on a new weight loss pill called amycretin showed that it could be more effective than Wegovy. Meanwhile, the FDA approved Johnson & Johnson's lung cancer medicine, Rybrevant, for first-line use.
3 High Yield Dividend Aristocrats To Buy Now
Article By:
SureDividend
Friday, February 2, 2024 4:00 PM EDT
The Dividend Aristocrats have increased their dividends every year for at least 25 years in a row.
Elliott Wave Technical Analysis: Johnson & Johnson - Friday, Jan. 26
Article By:
Peter Mathers
Friday, January 26, 2024 9:40 AM EDT
Looking for a break of {b} of 2 to enter long.
In this article: JNJ
Warren Buffett Stocks: Johnson & Johnson
#Buffett...Buffett...Buffett...loss Billions in oil...Apple lately.,...so?!
And $JNJ is way overbought.
It's Good To Be A Guinea Pig
It's crazy that they suspended the $JNJ vaccine because 6 people out of 7 million experience some adverse effects which did not even kill them. Meanwhile Covid has killed millions. Being that the JNJ vaccine had zero adverse effects in men, they should at least let me continue to get it. It's so hard to get vaccinated as is it.
How To Invest In Woman-Led Companies With ETFs & Stocks
Not until they remove cancer causing $JNJ from portfolio.
Johnson & Johnson: Recession Safety, Growth And Valuation
Inventors, do not trust johnson and Johnson $JNJ
Johnson & Johnson Upgraded To Neutral From Sell At Goldman Sachs
Still not impressed with $JNJ.